Sökning: "daniel aili"
Visar resultat 1 - 5 av 11 avhandlingar innehållade orden daniel aili.
1. Polypeptide-Based Nanoscale Materials
Sammanfattning : Self-assembly has emerged as a promising technique for fabrication of novel hybrid materials and nanostructures. The work presented in this thesis has been focused on developing nanoscale materials based on synthetic de novo designed polypeptides. LÄS MER
2. Tunable and modular assembly of polypeptides and polypeptide-hybrid biomaterials
Sammanfattning : Biomaterials are materials that are specifically designed to be in contact with biological systems and have for a long time been used in medicine. Examples of biomaterials range from sophisticated prostheses used for replacing outworn body parts to ordinary contact lenses. Currently it is possible to create biomaterials that can e.g. LÄS MER
3. Bioactive nanocellulose materials for the treatment of chronic wounds
Sammanfattning : Chronic wounds represent a burden for the healthcare system and significantly affect the quality of life of the patients. There is currently a lack of efficient treatments but new, improved therapeutic approaches are under development. LÄS MER
4. Multifunctional Nanocellulose Composite Materials
Sammanfattning : Nanoparticles (NPs) are particles with more than one dimension between 1 and 100 nm. Because of their small size, they typically display different physical and chemical properties than the corresponding bulk materials. NPs have been used in many different applications, such as in electronics, optics, catalysis, and in biomedicine. LÄS MER
5. Modular Hyaluronan-Based Hydrogels for 3D Cell Culture and Bioprinting
Sammanfattning : Three-dimensional (3D) cell culture facilitates development of biological relevant assays for drug screening and toxicity testing. Compared to conventional 2D cell culture, cells cultured in 3D can more accurately mimic human tissues and organs and thus provide ex vivo data with potentially better predictive value for cancer research, pharmacology, and toxicology, reducing the need for animal models, improving experimental reproducibility, and reducing time and costs in drug development. LÄS MER